Abvc Biopharma (ABVC) Return on Sales (2010 - 2025)
Abvc Biopharma's (ABVC) quarterly Return on Sales came in at 0.04% in Q4 2025, up 409.0% YoY from 0.01% in Q4 2024, and up 100.97% on a QoQ basis from 4.05% in Q4 2024.
Abvc Biopharma (ABVC) Return on Sales (2010 - 2025) Analysis & Trends
Abvc Biopharma (ABVC) has 13 years of Return on Sales data on file, last reported at 0.04% in Q4 2025.
- Quarterly Return on Sales rose 409.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.32% (up 42.0% YoY) and the FY2025 annual result came in at 2.64%, down 253.0% from the prior year.
- Return on Sales advanced to 0.04% in Q4 2025, from 4.05% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.18% in Q4 2021 to a low of 24.3% in Q1 2024.
- A 5-year average of 2.46% and a median of 0.19% in 2021 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales slumped 2415 bps — and 2025, when it soared 409 bps.
- Tracing ABVC's Return on Sales over 5 years: stood at 0.18% in 2021, then tumbled by 142 bps to 0.07% in 2022, then tumbled by 4296 bps to 3.23% in 2023, then retreated by 25 bps to 4.05% in 2024, then surged by 101 bps to 0.04% in 2025.
- The last three Return on Sales figures came in at 0.04% (Q4 2025), 4.05% (Q4 2024), and 0.01% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Abvc Biopharma | 22.93 Mn | 22.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.04% |
| Dec 31, 2024 | -4.05% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.09% |
| Mar 31, 2024 | -24.30% |
| Dec 31, 2023 | -3.23% |
| Sep 30, 2023 | -2.12% |
| Jun 30, 2023 | -3.79% |
| Mar 31, 2023 | -0.15% |
| Dec 31, 2022 | -0.07% |
| Sep 30, 2022 | -0.89% |
| Jun 30, 2022 | -0.06% |
| Mar 31, 2022 | -2.37% |
| Dec 31, 2021 | 0.18% |
| Sep 30, 2021 | -0.19% |
| Jun 30, 2021 | -0.65% |
| Mar 31, 2021 | -0.05% |
| Dec 31, 2020 | -0.80% |
| Sep 30, 2020 | -0.18% |
| Jun 30, 2020 | -0.10% |